Vitamin C and Skin Cancer Studies
They found that 86% of
basal cell carcinoma skin cancers were eliminated.
86%.
Wow.
Um, that's the most common type of skin
cancer.
And so it literally eradicated those in a vast majority of subjects
with the vitamin C and DMSO. And then they did a second study
recently that found over 50% of
squamous cell carcinoma skin cancer lesions
were eliminated. And s-
Wow. So tell me more about those two studies,
would you please?
Because I was diagnosed with a basal cell carcinoma right
here
They literally took a solution of vitamin C,
um, 30% ascorbic acid, which is vitamin C,
in a solution that is 95%, uh,
DMSO, dimethyl sulfoxide, mixed with 5%
water, right? So they have this solution, and they have an
applicator, like a brush. In both of these studies, the basal cell
carcinoma patients and the squamous cell carcinoma patients,
the two
most common types of skin cancers, they brushed it on their lesions,
lesions twice a day for about eight to 12 weeks
in these studies. And in the squamous cell carcinoma
patients, over 56% of those lesions literally
fell off and disappeared, and then the remaining shrunk by
over 85%, and 94% of them were able
to not get surgery, skip the surgery.
And again, so squamous cell is more dangerous.
And then we get to the least dangerous one, basal cell carcinoma.
Um, o- over 86% of those, of those
skin cancers fell off and were eliminated.
DMSO acts as a penetrator to allow
the vitamin C to enter. So what appears to be happening
is either both the DMSO and vitamin C have
anti-cancer activity, or just the vitamin C does, and the
DMSO is, is allowing the vitamin C to enter.
Either way, we know vitamin C has potent
anti-cancer activity across a variety of mechanisms,
and it's clearly evident in these human data.
So why do you think
it's taken so long for people to try to think of this?
It can't be patented.
Oh.
You can't patent DMSO, and you can't patent vitamin
C
End of transcript · 350 words